- Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction
- Inhaled corticosteroids for bronchiectasis
- Inhaled corticosteroids for cystic fibrosis
- Inhaled corticosteroids for non-specific chronic cough in children
- Inhaled corticosteroids for stable chronic obstructive pulmonary disease
- Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma
- Inhaled cromones for prolonged non-specific cough in children
- Inhaled hyperosmolar agents for bronchiectasis
- Inhaled magnesium sulfate in the treatment of acute asthma
- Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults
- Inhaled nitric oxide for respiratory failure in preterm infants
- Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
- Inhaled non‐steroid anti‐inflammatories for children and adults with bronchiectasis
- Inhaled short acting beta2‐agonist use in chronic asthma: regular versus as needed treatment
- Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
- Inhaled sodium cromoglycate for asthma in children
- Inhaled steroids for acute asthma following emergency department discharge
- Inhaled steroids for episodic viral wheeze of childhood
- Inhaled steroids with and without regular formoterol for asthma: serious adverse events
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.